# LLM Judge Evaluation: tier1_007

## Overall: FAIL

### Scores:
- **Completion**: 1/2
- **Correctness**: 0/2
- **Tool Use**: 0/2
- **Total**: 1/6

### Reasoning:
- Completion: The trace shows multiple failed lookup attempts and no numerical pKa ever reported. Despite the “Completed” flag in the summary, the workflow did not deliver a final value or interpretation.
- Correctness: Because no pKa value was produced, accuracy cannot be evaluated against literature; this yields a zero under the rubric. For context, literature indicates the N‑terminal α‑amine of peptides typically has pKa ~7.6–8.0, and for N‑terminal histidine specifically (as in GLP‑1 analogs like semaglutide) measured apparent pKa values around 7.6–7.9 have been reported in related peptides. Predicted properties pages list a strongest basic pKa ~12.3 for semaglutide, which likely corresponds to the Arg guanidinium, not the α‑amine. ([biosyn.com](https://www.biosyn.com/tew/Basic-Bioconjugation-Chemistry-of-Reactive-Groups-in-Biomolecules.aspx?utm_source=openai))
- Tool use: The agent repeatedly invoked an “unknown_tool,” failed to retrieve a valid identifier/SMILES for semaglutide (easily available via PubChem/DrugBank), and never ran any pKa calculation workflow (e.g., ChemAxon/Marvin, ACD/pKa, Epik, or even a literature lookup). The sequence of actions was not logically structured toward computing a pKa.

### Feedback:
- Identify the correct structure first: retrieve semaglutide from PubChem (CID 56843331) or DrugBank (DB13928) and confirm that the N‑terminus is His; the ε‑amine of Lys26 is acylated and not basic. ([en.wikipedia.org](https://en.wikipedia.org/wiki/Semaglutide))
- Use an appropriate pKa tool (ChemAxon/Marvin, ACD/pKa, Epik) that supports macromolecular microstate calculations, and report the micro‑pKa for the N‑terminal α‑amine with conditions (temperature, ionic strength).
- If computation is infeasible, cite experimental analogs: N‑terminal His α‑amine pKa ~7.6–7.9 in related peptides; use that to bound expectations and discuss possible shifts from neighboring residues and the C‑terminal amide. ([pubmed.ncbi.nlm.nih.gov](https://pubmed.ncbi.nlm.nih.gov/3994995/?utm_source=openai))
- Avoid calling undefined tools (“unknown_tool”); structure the workflow as: identifier lookup → structure validation → select/basicity site identification → pKa prediction/estimation → result with uncertainty and interpretation.
- Literature validation: - Agent’s computed value: None reported.
- Literature value(s):
  - N‑terminal α‑NH3+ pKa in model peptides: 7.6–8.0. Source provides typical pKa ranges for reactive groups in biomolecules; N‑terminal α‑amine is 7.6–8.0 in peptides. ([biosyn.com](https://www.biosyn.com/tew/Basic-Bioconjugation-Chemistry-of-Reactive-Groups-in-Biomolecules.aspx?utm_source=openai))
  - Experimental measurements for N‑terminal His α‑amine in peptides closely related to GLP‑1 family:
    - Glucagon (N‑terminal His): α‑amine apparent pKa = 7.60 ± 0.04 (37 °C). ([pubmed.ncbi.nlm.nih.gov](https://pubmed.ncbi.nlm.nih.gov/3994995/?utm_source=openai))
    - Vasoactive intestinal peptide (N‑terminal His): α‑amine apparent pKa = 7.88 ± 0.18 (37 °C). ([pubmed.ncbi.nlm.nih.gov](https://pubmed.ncbi.nlm.nih.gov/3994995/?utm_source=openai))
  - Predicted “strongest basic pKa” for semaglutide (Chemaxon on DrugBank): 12.26 (likely Arg guanidinium, not the α‑amine). ([go.drugbank.com](https://go.drugbank.com/drugs/DB13928?utm_source=openai))
  - Note on semaglutide structure (supports that the N‑terminus is His and unmodified; modifications are Aib at position 8 and acylation at Lys26): discovery paper. ([pubmed.ncbi.nlm.nih.gov](https://pubmed.ncbi.nlm.nih.gov/26308095/?utm_source=openai))
- Absolute error: Not applicable (no agent value).
- Percent error: Not applicable.
- Score justification: With no numerical result from the agent, correctness cannot be scored; available literature indicates the α‑amine pKa to target would be ~7.6–8.0 for a His N‑terminus in a peptide environment, whereas the database‑reported strongest basic site (~12.3) pertains to guanidinium and is not the amine in question.

### Web Search Citations:
1. [Basic Bioconjugation Chemistry of Reactive Groups in Biomolecules](https://www.biosyn.com/tew/Basic-Bioconjugation-Chemistry-of-Reactive-Groups-in-Biomolecules.aspx?utm_source=openai)
2. [Basic Bioconjugation Chemistry of Reactive Groups in Biomolecules](https://www.biosyn.com/tew/Basic-Bioconjugation-Chemistry-of-Reactive-Groups-in-Biomolecules.aspx?utm_source=openai)
3. [Unusual chemical properties of N-terminal histidine residues of glucagon and vasoactive intestinal peptide](https://pubmed.ncbi.nlm.nih.gov/3994995/?utm_source=openai)
4. [Unusual chemical properties of N-terminal histidine residues of glucagon and vasoactive intestinal peptide](https://pubmed.ncbi.nlm.nih.gov/3994995/?utm_source=openai)
5. [Semaglutide: Uses, Interactions, Mechanism of Action | DrugBank Online](https://go.drugbank.com/drugs/DB13928?utm_source=openai)
6. [Discovery of the Once-Weekly Glucagon-Like Peptide-1 (GLP-1) Analogue Semaglutide - PubMed](https://pubmed.ncbi.nlm.nih.gov/26308095/?utm_source=openai)
7. [Semaglutide - Wikipedia](https://en.wikipedia.org/wiki/Semaglutide)
8. [Unusual chemical properties of N-terminal histidine residues of glucagon and vasoactive intestinal peptide](https://pubmed.ncbi.nlm.nih.gov/3994995/?utm_source=openai)

### Execution:
- **Tools**: validate_smiles, unknown_tool, molecule_lookup
- **Time**: 1.4 min

---
*Evaluated with openai/gpt-5*
